BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23883213)

  • 1. Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.
    Fowler KJ; Sheybani A; Parker RA; Doherty S; M Brunt E; Chapman WC; Menias CO
    AJR Am J Roentgenol; 2013 Aug; 201(2):332-9. PubMed ID: 23883213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined hepatocellular carcinoma and cholangiocarcinoma (biphenotypic) tumors: clinical characteristics, imaging features of contrast-enhanced ultrasound and computed tomography.
    Li R; Yang D; Tang CL; Cai P; Ma KS; Ding SY; Zhang XH; Guo DY; Yan XC
    BMC Cancer; 2016 Feb; 16():158. PubMed ID: 26917546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Features of Biphenotypic Primary Liver Carcinoma (Hepatocholangiocarcinoma) and the Potential to Mimic Hepatocellular Carcinoma: LI-RADS Analysis of CT and MRI Features in 61 Cases.
    Potretzke TA; Tan BR; Doyle MB; Brunt EM; Heiken JP; Fowler KJ
    AJR Am J Roentgenol; 2016 Jul; 207(1):25-31. PubMed ID: 26866746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intrahepatic peripheral cholangiocarcinomas as mimics of hepatocellular carcinoma in multiphasic CT.
    Mendiratta-Lala M; Park H; Kolicaj N; Mendiratta V; Bassi D
    Abdom Radiol (NY); 2017 Jan; 42(1):171-178. PubMed ID: 27590067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential diagnostic performance of contrast-enhanced ultrasound and tumor markers in differentiating combined hepatocellular-cholangiocarcinoma from hepatocellular carcinoma and cholangiocarcinoma.
    Huang XW; Huang Y; Chen LD; Wang Z; Yang Z; Liu JY; Xie XY; Lu MD; Shen SL; Wang W
    J Med Ultrason (2001); 2018 Apr; 45(2):231-241. PubMed ID: 29052791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoepithelioma-like cholangiocarcinoma: a mimic of hepatocellular carcinoma on imaging features.
    Liao TC; Liu CA; Chiu NC; Yeh YC; Chiou YY
    World J Gastroenterol; 2015 Apr; 21(13):4089-95. PubMed ID: 25852298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined Hepatocellular Cholangiocarcinoma (Biphenotypic) Tumors: Potential Role of Contrast-Enhanced Ultrasound in Diagnosis.
    Li F; Han J; Han F; Wang JW; Luo RZ; Li AH; Zhou JH
    AJR Am J Roentgenol; 2017 Oct; 209(4):767-774. PubMed ID: 28777653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging features of hepatic sarcomatous carcinoma on computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.
    Gu KW; Kim YK; Min JH; Ha SY; Jeong WK
    Abdom Radiol (NY); 2017 May; 42(5):1424-1433. PubMed ID: 28078380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of biphasic spiral CT and MnDPDP-enhanced MRI in the detection and characterization of liver lesions].
    Grimm J; Müller-Hülsbeck S; Blume J; Biederer J; Heller M
    Rofo; 2001 Mar; 173(3):266-72. PubMed ID: 11293872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hepatocellular-cholangiocarcinoma: what the radiologist needs to know about biphenotypic liver carcinoma.
    Shetty AS; Fowler KJ; Brunt EM; Agarwal S; Narra VR; Menias CO
    Abdom Imaging; 2014 Apr; 39(2):310-22. PubMed ID: 24407728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver.
    Kim SJ; Lee JM; Han JK; Kim KH; Lee JY; Choi BI
    AJR Am J Roentgenol; 2007 Dec; 189(6):1428-34. PubMed ID: 18029881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014.
    Horvat N; Nikolovski I; Long N; Gerst S; Zheng J; Pak LM; Simpson A; Zheng J; Capanu M; Jarnagin WR; Mannelli L; Do RKG
    Abdom Radiol (NY); 2018 Jan; 43(1):169-178. PubMed ID: 28765978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accurate preoperative evaluation of liver mass lesions without fine-needle biopsy.
    Torzilli G; Minagawa M; Takayama T; Inoue K; Hui AM; Kubota K; Ohtomo K; Makuuchi M
    Hepatology; 1999 Oct; 30(4):889-93. PubMed ID: 10498639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: role of biopsy.
    Sersté T; Barrau V; Ozenne V; Vullierme MP; Bedossa P; Farges O; Valla DC; Vilgrain V; Paradis V; Degos F
    Hepatology; 2012 Mar; 55(3):800-6. PubMed ID: 22006503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinoma.
    Sagrini E; Iavarone M; Stefanini F; Tovoli F; Vavassori S; Maggioni M; Renzulli M; Salvatore V; Stefanescu H; Colombo M; Bolondi L; Piscaglia F
    United European Gastroenterol J; 2019 Feb; 7(1):69-77. PubMed ID: 30788118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 18F-FDG PET Scan and Ultrasound-guided Biopsy in the Diagnosis of Hepatic Carcinomas.
    Shao H; Cheng W; Yu L; Li Y; Jing H
    Hepatogastroenterology; 2015 Jun; 62(140):978-81. PubMed ID: 26902040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of combined hepatocellular and cholangiocarcinomas on enhanced CT: comparison with histologic findings.
    Nishie A; Yoshimitsu K; Asayama Y; Irie H; Aibe H; Tajima T; Shinozaki K; Nakayama T; Kakihara D; Shimada M; Aishima S; Yoshida K; Honda H
    AJR Am J Roentgenol; 2005 Apr; 184(4):1157-62. PubMed ID: 15788587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic enhancement patterns of intrahepatic cholangiocarcinoma in cirrhosis on contrast-enhanced computed tomography: risk of misdiagnosis as hepatocellular carcinoma.
    Li R; Cai P; Ma KS; Ding SY; Guo DY; Yan XC
    Sci Rep; 2016 May; 6():26772. PubMed ID: 27226026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features and computed tomographic findings.
    Aoki K; Takayasu K; Kawano T; Muramatsu Y; Moriyama N; Wakao F; Yamamoto J; Shimada K; Takayama T; Kosuge T
    Hepatology; 1993 Nov; 18(5):1090-5. PubMed ID: 7693572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.